Literature DB >> 9119808

KATP channel opening does not contribute significantly to the vasodilatory effect of SH-group-containing ACE inhibitors.

H Köppel1, S Holzmann, W Klein, E Horn, S Horn, R Gasser.   

Abstract

Angiotensin-converting enzyme (ACE) inhibitors are widely used in the management of hypertension, heart failure, and nephropathy. It has been suggested that ACE inhibitors containing the sulfhydryl group (SH) have an additional effect on KATP channels. To prove this hypothesis, we studied the effects of the SH-containing ACE inhibitors, captopril and zofenopril, on KATP channel opening of bovine coronary arteries and guinea pig thoracic aortas. Bovine coronary arteries were precontracted with the thromboxane A2 analogue, U46619, and guinea pig thoracic aortas were precontracted with phenylephrine and then relaxed with either captopril or zofenopril (n = 8). Inhibition of KATP channel opening with glibenclamide moderately attenuated the zofenopril-induced relaxation of guinea pig thoracic aorta. However, in the bovine coronary arteries, the relaxing effect of both captopril and zofenopril remained uneffected by glibenclamide. In experiments with enalapril (a non SH-containing ACE inhibitor; n = 6) on guinea pig thoracic aortas, no effect on KATP channels could be seen. From our experiments, we conclude that the postulated opening of KATP channels by SH-group-containing ACE inhibitors contributes little to the vasodilation of guinea pig thoracic aortas caused by ACE inhibitors, and that SH groups have no influence upon KATP channels of bovine coronary arteries.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9119808     DOI: 10.1007/bf02559991

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  16 in total

1.  Myocardial hibernation.

Authors:  R Gasser; C Furian; M Grisold; J Dusleag; W Klein
Journal:  Lancet       Date:  1992-09-26       Impact factor: 79.321

Review 2.  Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone.

Authors:  M T Nelson; J B Patlak; J F Worley; N B Standen
Journal:  Am J Physiol       Date:  1990-07

Review 3.  The renin-angiotensin system.

Authors:  I A Reid; B J Morris; W F Ganong
Journal:  Annu Rev Physiol       Date:  1978       Impact factor: 19.318

4.  Release of adrenal catecholamines by angiotensin I.

Authors:  M J Peach; F M Bumpus; P A Khairallah
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

Review 5.  Cardiovascular and biological effects of K+ channel openers, a class of drugs with vasorelaxant and cardioprotective properties.

Authors:  C Richer; J Pratz; P Mulder; S Mondot; J F Giudicelli; I Cavero
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

6.  Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle.

Authors:  N B Standen; J M Quayle; N W Davies; J E Brayden; Y Huang; M T Nelson
Journal:  Science       Date:  1989-07-14       Impact factor: 47.728

7.  Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.

Authors:  C A Sargent; P G Sleph; S Dzwonczyk; M A Smith; D Normandin; M J Antonaccio; G J Grover
Journal:  J Pharmacol Exp Ther       Date:  1993-05       Impact factor: 4.030

8.  Molecular mechanism of action of nicorandil.

Authors:  W R Kukovetz; S Holzmann; G Pöch
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

9.  Adenosine-activated potassium current in smooth muscle cells isolated from the pig coronary artery.

Authors:  C Dart; N B Standen
Journal:  J Physiol       Date:  1993-11       Impact factor: 5.182

Review 10.  Contractile failure in early myocardial ischemia: models and mechanisms.

Authors:  R N Gasser; W Klein
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.